BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25232501)

  • 1. STAT5 N-domain deleted isoforms are naturally occurring hypomorphs partially rescued in hematopoiesis by transgenic Bcl-2 expression.
    Wang Z; Li G; Bunting KD
    Am J Blood Res; 2014; 4(1):20-6. PubMed ID: 25232501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT5 requires the N-domain to maintain hematopoietic stem cell repopulating function and appropriate lymphoid-myeloid lineage output.
    Li G; Wang Z; Zhang Y; Kang Z; Haviernikova E; Cui Y; Hennighausen L; Moriggl R; Wang D; Tse W; Bunting KD
    Exp Hematol; 2007 Nov; 35(11):1684-94. PubMed ID: 17976521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A STAT5 modifier locus on murine chromosome 7 modulates engraftment of hematopoietic stem cells during steady-state hematopoiesis.
    Couldrey C; Bradley HL; Bunting KD
    Blood; 2005 Feb; 105(4):1476-83. PubMed ID: 15498858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stromal STAT5-Mediated Trophic Activity Regulates Hematopoietic Niche Factors.
    Wang Z; Emmel G; Lim HS; Zhu W; Kosters A; Ghosn EEB; Qiu P; Bunting KD
    Stem Cells; 2023 Oct; 41(10):944-957. PubMed ID: 37465968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. STAT5 requires the N-domain for suppression of miR15/16, induction of bcl-2, and survival signaling in myeloproliferative disease.
    Li G; Miskimen KL; Wang Z; Xie XY; Brenzovich J; Ryan JJ; Tse W; Moriggl R; Bunting KD
    Blood; 2010 Feb; 115(7):1416-24. PubMed ID: 20008792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematopoietic-repopulating defects from STAT5-deficient bone marrow are not fully accounted for by loss of thrombopoietin responsiveness.
    Bradley HL; Couldrey C; Bunting KD
    Blood; 2004 Apr; 103(8):2965-72. PubMed ID: 15070672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stat5-deficient hematopoiesis is permissive for Myc-induced B-cell leukemogenesis.
    Wang Z; Medrzycki M; Bunting ST; Bunting KD
    Oncotarget; 2015 Oct; 6(30):28961-72. PubMed ID: 26338970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced lymphomyeloid repopulating activity from adult bone marrow and fetal liver of mice lacking expression of STAT5.
    Bunting KD; Bradley HL; Hawley TS; Moriggl R; Sorrentino BP; Ihle JN
    Blood; 2002 Jan; 99(2):479-87. PubMed ID: 11781228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells.
    Bradley HL; Hawley TS; Bunting KD
    Blood; 2002 Dec; 100(12):3983-9. PubMed ID: 12393407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT5 signaling in normal and pathologic hematopoiesis.
    Bunting KD
    Front Biosci; 2007 May; 12():2807-20. PubMed ID: 17485261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gab2 promotes hematopoietic stem cell maintenance and self-renewal synergistically with STAT5.
    Li G; Wang Z; Miskimen KL; Zhang Y; Tse W; Bunting KD
    PLoS One; 2010 Feb; 5(2):e9152. PubMed ID: 20161778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. STAT5 in hematopoietic stem cell biology and transplantation.
    Wang Z; Bunting KD
    JAKSTAT; 2013 Oct; 2(4):e27159. PubMed ID: 24498540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT5 activation in B-cell acute lymphoblastic leukemia: damned if you do, damned if you don't.
    Wang Z; Bunting KD
    Cancer Cell Microenviron; 2016; 3(1):. PubMed ID: 26973852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation.
    Kieslinger M; Woldman I; Moriggl R; Hofmann J; Marine JC; Ihle JN; Beug H; Decker T
    Genes Dev; 2000 Jan; 14(2):232-44. PubMed ID: 10652277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gain-of-function of Stat5 leads to excessive granulopoiesis and lethal extravasation of granulocytes to the lung.
    Lin WC; Schmidt JW; Creamer BA; Triplett AA; Wagner KU
    PLoS One; 2013; 8(4):e60902. PubMed ID: 23565285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-terminal deletion augments the cell-death-inducing activity of BAX in adenoviral gene delivery to nonsmall cell lung cancers.
    Usui K; Saijo Y; Narumi K; Koyama S; Maemondo M; Kikuchi T; Tazawa R; Hagiwara K; Ishibashi Y; Ohta S; Nukiwa T
    Oncogene; 2003 May; 22(17):2655-63. PubMed ID: 12730679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel transcript encoding an N-terminally truncated AML1/PEBP2 alphaB protein interferes with transactivation and blocks granulocytic differentiation of 32Dcl3 myeloid cells.
    Zhang YW; Bae SC; Huang G; Fu YX; Lu J; Ahn MY; Kanno Y; Kanno T; Ito Y
    Mol Cell Biol; 1997 Jul; 17(7):4133-45. PubMed ID: 9199349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The IL-2 receptor promotes lymphocyte proliferation and induction of the c-myc, bcl-2, and bcl-x genes through the trans-activation domain of Stat5.
    Lord JD; McIntosh BC; Greenberg PD; Nelson BH
    J Immunol; 2000 Mar; 164(5):2533-41. PubMed ID: 10679091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Restricted STAT5 activation dictates appropriate thymic B versus T cell lineage commitment.
    Goetz CA; Harmon IR; O'Neil JJ; Burchill MA; Johanns TM; Farrar MA
    J Immunol; 2005 Jun; 174(12):7753-63. PubMed ID: 15944278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line.
    Dumon S; Santos SC; Debierre-Grockiego F; Gouilleux-Gruart V; Cocault L; Boucheron C; Mollat P; Gisselbrecht S; Gouilleux F
    Oncogene; 1999 Jul; 18(29):4191-9. PubMed ID: 10435632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.